Get Enquiry

Category Details :

The treatment of different cancers, particularly non-small cell lung cancer (NSCLC), has been transformed by a class of targeted cancer medicines known as epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs). The Epidermal Growth Factor Receptor (EGFR), a cell surface protein that is essential for controlling cell growth and..

Read More
Enquiry Now